Ads for gene tests test AMA, California

Share this article:
The American Medical Association's House of Delegates adopted a resolution calling for “appropriate organizations” to develop criteria for the advertising of DTC genetic tests, a sector increasingly shelling out big bucks for consumer advertising. Delegates were concerned that patients are ordering tests they don't need and/or can't interpret properly because they saw a service advertised. Meanwhile, the state of California sent cease and desist letters to 13 companies that offer genetic testing, demanding that they stop testing until they prove that the labs they use are state licensed and that doctors, not patients, ordered the tests.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?